Point-of-Care Coagulation Testing Devices Market Trends Size Estimated to Observe Significant Growth by 2027

Healthcare Companies Expedite Hemostasis Management with Advanced Point-of-Care Coagulation Testing Devices

Healthcare companies in the point-of-care coagulation testing devices market are developing analyzers that meet the quality control standards laid down by central laboratories. They are increasing expertise in the development of POC (point-of-care) devices that generate timely results. With the surging trend of self-monitoring, patients can be assured of lab-accurate PT/INR (Prothrombin Time/International Normalized Ratio) results, with advancements in POC coagulation testing systems. As such, healthcare companies in the point-of-care coagulation testing devices market are developing mobile handheld devices that help improve outcomes and serve the convenience of patients who have undergone major surgeries.

Several advantages of POC coagulation testing are adding value for patients regarding hemostatic management, both, in and out of the hospital. Currently, manufacturers in the point-of-care coagulation testing devices landscape are creating the increased availability of POC devices for hospitals, since hospitals hold the highest revenue share amongst all the end-users in the landscape, with a value of ~US$ 500 million in 2018. Thus, during emergency cases in ICUs, coronary care units, and during surgeries, POC devices help provide immediate and actionable results to healthcare providers. As such, healthcare companies in the point-of-care coagulation testing devices market are tapping into incremental opportunities by expediting hemostasis management amongst patients in a range of settings, such as outpatient clinics, physician offices, pharmacies, and healthcare centres. For instance, in April 2018, Roche - a Swiss multinational healthcare company, announced the launch of CoaguChek^® Vantus system, a self-testing device, enabled with the wireless reporting of INR results.

Request the Coronavirus Impact Analysis on this Markets - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=56190

point of care coagulation testing market

To know the scope of our report Get a Sample on Point-of-Care Coagulation Testing Devices Market

Miniaturized POC Devices and Infrared Spectroscopy Help in Assessing Response to Anticoagulants

The alarming prevalence of coagulation amongst patients, worldwide, has persuaded manufacturers in the point-of-care coagulation testing devices market to innovate improved diagnostic analyzers. Automated analyzers are being increasingly used to test latex agglutination and enzymatic immunoassays. With increased advancements in technology, POC devices are becoming more and more mainstream for the routine diagnosis of hemostasis disorders. As such, POC devices are gaining popularity amongst patients, since they alleviate the hassle of increased costs and loss of blood in traditional hemostasis management techniques.

Get a glimpse of the in-depth analysis through our Report Brochure

Manufacturers in the point-of-care coagulation testing devices market are focusing on technological advancements that involve the introduction of acoustic waves in miniaturized POC devices and infrared spectroscopy. Miniaturized POC devices are novel technology, capable of using only a small amount of citrated whole blood to derive outcomes. These devices provide results within seconds and are useful for healthcare providers to study the effects of anticoagulants amongst patients. Likewise, healthcare companies in the point-of-care coagulation testing devices market are offering fast turnaround time through infrared spectroscopy devices, which is an important value addition to the category of handheld POC coagulometers. It has been found that these devices may be useful in assessing coagulation response to any direct oral anticoagulants consumed by patients.

Increasing Trend of Home Care Services and Self-Monitoring Reviving Market Growth

The point-of-care coagulation testing devices market is estimated to grow at a healthy CAGR of ~6% over the forecast period. However, certain challenges in the landscape are likely to negatively influence market growth.

There has been a general debate whether point-of-care testing is more reliable than the coagulation tests conducted at central laboratory. After several clinical trials, it was found that, the test results at central labs are more reliable than the results obtained from POC devices. It was also found that, the results obtained from POC devices are less conclusive as compared to those obtained from central labs. This phenomena is anticipated to impede market growth to some extent. Vice versa, it has been found that, laboratory plasma coagulation tests such as INR and aPTT (Activated Partial Thromboplastin Time) are not sufficient to diagnose specific coagulation conditions. Hence, patients are turning toward POC testing to overcome the limitations of traditional approaches catering to hemostatic therapy. Healthcare companies in the point-of-care coagulation testing devices market are increasing their efforts to demonstrate the success of POC testing after major surgeries.

Although the results acquired from labs are more reliable, the trend of home care services and self-monitoring is reviving market growth. Hence, healthcare companies in the point-of-care coagulation testing devices market are innovating new offerings in the healthcare space.

point of care coagulation testing market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Health_Whirl

Search This Blog